Understanding the pressing need to engage all healthcare providers to protect kids' well-being amid the difficulties of ecological contamination and environmental change.
Sibylla Biotech declared a drug discovery joint pact with Osaka-settled Ono pharma for getting to Sibylla's state of the art Pharmacological Protein Inactivation by Folding Intermediates Targeting (PPI-FIT) innovation to distinguish and foster...
Bayer and Aignostics GmbH declared an strategic partnership on artificial intelligence (AI)- fueled approaches with applications in precision oncology drug innovative work. Aignostics is a side project from one of the world's driving medical...
Eris Lifesciences declared the acquisition of Biocon Biologics' India-marked detailing business for Rs. 1,242 crore. Eris has likewise marked a 10-year supply concurrence with Biocon Biologics on account of this agreement...
Xcode Life, a prominent personal genomics company in India, has recently launched a new genetic test named "Genes and Caffeine."
The American Oncology Institute (AOI) at Babina Specialty Hospital in Imphal has recently initiated iodine therapy to treat thyroid cancer.
NephroPlus, the leading multinational dialysis care provider and Asia's largest dialysis network, recently announced the successful acquisition of Renal Therapy Solutions Inc. (RTSI).
According to a recent report by the World Health Organization, the gender gap in global healthcare is still a pressing issue.
Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for Prevenar 20, the company's 20-valent pneumococcal conjugate vaccine, for active immunization in infants, children, and adolescents
Sanofi India Limited (SIL) recently obtained approval from its board of directors for an exclusive distribution and promotion agreement with Emcure Pharmaceuticals Limited (Emcure).
, CDSCO.jpg)
